Recommendation for patients who have been treated with csDMARDs, excluding methotrexate, and who have moderate-to-high disease activity (Table 2) Recommendations are the same as for DMARD-naive patients except for this population. The strength of the following recommendation is conditional for all bDMARDs and tsDMARDs. Methotrexate monotherapy is conditionally recommended over the combination of methotrexate plus a bDMARD or tsDMARD The recommendation is conditional because the voting panel